Search research articles
Contact Us
Filters
Showing results (41-50 of 139) with videos related to
Page
of 14
Sort By:
Molecular Medicine Today
|
February 1, 2000
Does dysregulation of the Notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer's disease?
B H Anderton, R Dayanandan, R Killick, et al.
Lancet (London, England)
|
June 22, 1996
Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium
S Lovestone, G Wilcock, M Rossor, et al.
Neuroscience
|
August 1, 1996
Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules
S Lovestone, C L Hartley, J Pearce, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 20, 2004
Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype
J Cervilla, M Prince, S Joels, et al.
Neuroscience Letters
|
November 17, 2012
Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH
R Killick, T R Hughes, B P Morgan, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 17, 2000
Long-term predictors of cognitive outcome in a cohort of older people with hypertension
J A Cervilla, M Prince, S Joels, et al.
Cognitive Neuropsychiatry
|
September 21, 2011
The role of premorbid personality and cognitive factors in awareness of illness, memory, and behavioural functioning in Alzheimer's disease
J Gilleen, K Greenwood, N Archer, et al.
Journal of Medical Genetics
|
February 1, 1996
Familial psychiatric presentation of Huntington's disease
S Lovestone, S Hodgson, P Sham, et al.
Lancet (London, England)
|
April 27, 1996
Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group
P Kehoe, J Williams, S Lovestone, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1995
Consensus statement on predictive testing for Alzheimer disease
H Brodaty, M Conneally, S Gauthier, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 139) with videos related to
Sort By:
Page
of 14
Molecular Medicine Today
|
February 1, 2000
Does dysregulation of the Notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer's disease?
B H Anderton, R Dayanandan, R Killick, et al.
Lancet (London, England)
|
June 22, 1996
Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium
S Lovestone, G Wilcock, M Rossor, et al.
Neuroscience
|
August 1, 1996
Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules
S Lovestone, C L Hartley, J Pearce, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 20, 2004
Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype
J Cervilla, M Prince, S Joels, et al.
Neuroscience Letters
|
November 17, 2012
Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH
R Killick, T R Hughes, B P Morgan, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 17, 2000
Long-term predictors of cognitive outcome in a cohort of older people with hypertension
J A Cervilla, M Prince, S Joels, et al.
Cognitive Neuropsychiatry
|
September 21, 2011
The role of premorbid personality and cognitive factors in awareness of illness, memory, and behavioural functioning in Alzheimer's disease
J Gilleen, K Greenwood, N Archer, et al.
Journal of Medical Genetics
|
February 1, 1996
Familial psychiatric presentation of Huntington's disease
S Lovestone, S Hodgson, P Sham, et al.
Lancet (London, England)
|
April 27, 1996
Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group
P Kehoe, J Williams, S Lovestone, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1995
Consensus statement on predictive testing for Alzheimer disease
H Brodaty, M Conneally, S Gauthier, et al.
Page
of 14